HomeIPSC • NASDAQ
add
Century Therapeutics Inc
Previous close
$2.30
Day range
$2.25 - $2.40
Year range
$1.28 - $5.51
Market cap
201.96M USD
Avg Volume
298.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 855.00K | -50.29% |
Operating expense | 8.74M | -1.79% |
Net income | -28.06M | 10.24% |
Net profit margin | -3.28K | -80.57% |
Earnings per share | -0.45 | 15.09% |
EBITDA | -28.08M | 3.74% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 192.02M | -23.64% |
Total assets | 348.51M | -23.61% |
Total liabilities | 170.62M | -4.71% |
Total equity | 177.88M | — |
Shares outstanding | 82.85M | — |
Price to book | 0.84 | — |
Return on assets | -22.07% | — |
Return on capital | -34.23% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -28.06M | 10.24% |
Cash from operations | -30.25M | -3.52% |
Cash from investing | 11.54M | -63.17% |
Cash from financing | 18.20M | 3,961.38% |
Net change in cash | -512.00K | -119.95% |
Free cash flow | -19.70M | 20.59% |
About
Founded
2018
Headquarters
Website
Employees
152